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Understanding how certain protein toxins from the normally insecticidal bacterium Bacillus thuringiensis9
target human cell lines has implications for both the risk assessment of products containing these toxins and10
potentially for cancer therapy. This understanding requires knowledge of whether the human cell active toxins11
work by the same mechanism as their insecticidal counterparts or by alternative ones. The B. thuringiensis12
Cry41Aa (also known as Parasporin3) toxin is structurally related to the toxins synthesized by commercially13
produced transgenic insect-resistant plants, with the notable exception of an additional C-terminal beta-trefoil14
ricin domain. To better understand its mechanism of action we developed an efficient expression system for the15
toxin and created mutations in regions potentially involved in the toxic mechanism. Deletion of the ricin domain16
did not significantly affect the activity of the toxin against the human HepG2 cell line suggesting that this region17
was not responsible for the mammalian specificity of Cry41Aa. Various biochemical assays suggested that unlike18
some other human cell active toxins from B. thuringiensis Cry41Aa did not induce apoptosis but that its19
mechanism of action was consistent with that of a pore-forming toxin. The toxin induced a rapid and significant20
decrease in metabolic activity. ATP depletion, cell swelling, and membrane damage were also observed. An21
exposed loop region believed to be involved in receptor binding of insecticidal Cry toxins was shown to be22
important for the activity of Cry41Aa against HepG2 cells.23
24
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Introduction31
Bacillus thuringiensis (Bt) is best known as an entomopathogenic bacterium used commercially to control various32
insects and nematodes (1). The main active ingredients of Bt based products are proteins known as Cry toxins.33
These are pore-forming toxins that target the epithelial cells of the insect gut following ingestion, and lead to the34
death of the organism (2). The genes encoding these toxins have been expressed in different crop species to35
produce insect resistant transgenic varieties (3). To date around 300 different Cry toxin genes have been cloned36
from B. thuringiensis (4). Although most of these toxins are active against insects, a subset, known as parasporins,37
have been shown to have activity against human cell lines (5). Interestingly a variety of different toxicity38
mechanisms have been proposed for this group of toxins. These include cell death induced by pore-formation or39
via a calcium-dependent apoptotic signalling pathway (5). There are currently six different classes of parasporin40
toxin (6) of which three (PS1, 3 and 6) are particularly interesting since the toxins are structurally very similar to41
those expressed by insect-resistant transgenic crops. These parasporins contain some, or all, of the five conserved42
sequence blocks that are a characteristic of many Cry toxins (5) and are believed to adopt a three domain structure43
similar to GM-crop expressed toxins such as Cry1Ac. The focus of this study was the PS3 toxin (Cry41Aa), a44
split toxin encoded by two separate ORFS. The gene encoding Cry41Aa is found within a three gene operon with45
ORF2 encoding the functional portion of the toxin and ORF3 a protein believed to be important for expression46
within Bt. The first gene (ORF1) has no known function. Cry41Aa ORF2 contains an additional domain at its C-47
terminus which is not found in insecticidal toxins such as Cry1Ac (7). This domain (pfam14200 ricin type beta48
trefoil lectin-like domain) has been implicated in binding to carbohydrates on a cell surface (8) and so could confer49
particular specificities to the Cry41Aa toxin. Toxins isolated from a strain (A1462) encoding both Cry41Aa and50
the related Cry41Ab were found to be toxic to two human cell lines (HepG2 and HL60) but non-toxic to other cell51
lines including HeLa (7). Importantly toxicity was only observed after proteolytic treatment of the toxins.52
Proteolytic activation is believed to be a crucial step in the mechanism of action of many bacterial toxins (9)53
including B. thuringiensis Cry toxins (3). The aim of this study was to build on previous work that had54
demonstrated the activity of Cry41Aa on HepG2 cells by investigating whether or not the ricin domain has a role55
to play in specificity determination, and by clarifying the molecular basis of the toxicity mechanism.56
57
58
59
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Experimental60
Cloning of cry41Aa with and without its ricin domain61
Two PCR primers were designed to amplify ORF2 and ORF3 from the cry41Aa operon and incorporate suitable62
restriction sites. The forward primer (GAAGAAGGATCCAAATGGAATGGAGG) incorporated a BamHI site63
(underlined) 22bp upstream from the ORF2 start codon whereas the reverse primer64
(CGCTTCTAGAAGCCTGCTACCATTAC) incorporated an XbaI site 16bp downstream of ORF3. These65
primers allowed the two genes, and their ribosome binding sites, to be cloned into the Bt expression vector66
pSVP27a (10) using BamHI and XbaI. This vector places cloned genes under the control of the promoter for the67
Bt Cyt1Aa toxin gene. The resulting vector (pSVP2741Aa) was introduced into the acrystalliferous Bt strain 4D768
obtained from the Bacillus Genetic Stock Center. To remove the ricin domain primers were designed to amplify69
the entire toxin encoding plasmid but excluding the ricin domain. The forward primer70
(TAAAGGTGTGCAACTATCCCTTGAC) included the stop codon of ORF2 at its 5’ end whereas the 5’ end of71
the reverse primer (TCGAGTGGTTAAGCCAATACCC) encoded the 713th codon of ORF2. Following72
amplification the PCR product was self-ligated to give a plasmid (pSVP2741Aaǻricin) encoding the Cry41Aa73
toxin with amino acids 714-825 deleted. This plasmid was also introduced into Bt strain 4D7. Whole plasmid PCR74
was also used to create the single amino acid substitutions. All constructs were verified by DNA sequencing.75
76
Toxin expression and purification77
Recombinant Bacillus thuringiensis strains were grown on LB plates containing 5µg/ml chloramphenicol for 378
days at 30ºC. Cells containing spores and protoxin crystals were sonicated in water and then washed twice in79
0.3M NaCl before a final resuspension in water. The protoxin was solubilized in 50mM Na2CO3 buffer pH 10.5 /80
5mM DTT at 37ºC for one hour. Trypsin was added to the supernatant at a concentration of 1mg trypsin per mg81
protoxin and the sample incubated for a further hour at 37ºC. Protease inhibitor (Roche complete mini EDTA-82
free) was added before the activated toxin was purified on a 15ml Sephacryl S-200 High Resolution (Amersham)83
gel filtration column. Fractions were eluted in 25mM Tris/150mM NaCl (pH 7.4) and analysed by 7.5% SDS-84
PAGE and their concentration determined by the Bradford method using a Bio-Rad Protein Assay Kit using BSA85
as the standard.86
87
Cell culture88
The human hepatocellular carcinoma cell line (HepG2) was purchased from the European Collection of Cell89
Cultures (ECCAC; Salisbury, UK). HeLa cells came from an existing lab stock. Both cell lines were maintained90
in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine serum, 100 U/mL91
penicillin, 100 ȝg/mL streptomycin, 292 ȝg/mL L-glutamine at 37°C in a humidified 5% CO2 incubator. When92
the cells reached 70-80% confluency they were split using 0.05% Trypsin-EDTA.93
94
Cell assays95
Cell viability was assessed using the Promega CellTiter-Blue assay as an endpoint method with a 2 hour incubation96
with the assay reagent. ATP levels were measured using Promega CellTiter-Glo. Analysis of apoptosis was97
performed using Promega Caspase-Glo 3/7. Membrane integrity was determined with Promega CellTox Green98
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assay using ‘Express, No-Step Addition at Seeding Method’ and Promega CytoTox-Glo. Hydrogen peroxide99
production was tested with Promega ROS-Glo H2O2 assay in the presence of 1mM sodium pyruvate. All cell assay100
kits were used according to the manufacturer’s instructions. Where applicable, data were normalised for101
background fluorescence/luminescence. 90 µl of cell suspension (containing 22500 cells, unless otherwise102
specified) were dispensed in triplicate into a 96-well plate.  After 20 hour incubation each well received 10µl of103
the appropriate control/test substance. Unless otherwise specified purified, trypsin-activated toxins were used in104
all assays. The data shown are representative results of independently repeated experiments each involving 3105
technical replicates, error bars represent one standard error of the mean.106
107
Results108
Expression of recombinant Cry41Aa109
The cry41Aa gene is found as part of a three gene operon in Bt strain A1462 in which the second ORF encodes110
the active toxin whilst the third one encodes a protein believed to aid crystallization and expression. Initial111
experiments confirmed that when expressed in the acrystalliferous Bt strain 4D7 both ORFs were expressed with112
apparent molecular weights of 107kDa (ORF3) and 78kDa (ORF2) (Fig 1, lane 1). Following deletion of the ricin113
domain, SDS PAGE analysis showed expression of both the truncated ORF2 (66kDa) and full length ORF3 as114
expected (Fig. 1, lane 2). Solubilization and proteolytic activation of the recombinant toxins resulted in proteins115
slightly smaller (by around 4kDa) than their respective unprocessed ORF2 toxins (Fig. 1 lanes 5&6). The ORF3116
protein was degraded by trypsin.117
118
Effect of the recombinant toxins on the viability of HepG2cells119
The solubilised protoxin form of Cry41Aa, even at a high dose (300 ȝg/ml), had little effect on the viability of120
HepG2 cells as assessed using the CellTiter Blue cell viability assay (Fig. 2A). In contrast, activated toxin reduced121
viability by almost 50% at a concentration of only 10 µg/ml and was significantly more active than the mock122
control (unpaired t-test P<0.005). There was no significant difference (unpaired t-test P>0.05) between the ricin123
deleted form of Cry41Aa and the non-modified form indicating that the ricin domain does not mediate the toxic124
effects of Cry41Aa on HepG2 cells. Control samples included buffer alone and trypsin-treated proteins from an125
alternative recombinant strain of B. thuringiensis - 4D7 expressing the insecticidal Cry1Ca toxin. Neither of these126
showed any toxicity towards HepG2 cells. As previously reported (11) HeLa cells were not sensitive to protease-127
activated Cry41Aa (Fig. 2B). The effect of the toxin on HepG2 cells was relatively quick since maximum toxicity128
was observed following 2 hours of exposure to the toxin (data not shown). Since we found no evidence of any129
difference in activity between the full length and ricin-deleted forms of the toxin subsequent studies to probe the130
mechanism of action of the toxin were only performed on the full-length toxin. In order to establish an EC50 value131
for Cry41Aa, a dose response experiment was performed (Fig. 2C). Probit analysis generated an EC50 value of132
2.17µg/ml (95% CL 1.96-2.41).133
134
Mechanism of action of Cry41Aa on HepG2 cells135
Analysis of another parasporin toxin (Cry31Aa) that shares the same toxin protein fold as Cry41Aa indicated that136
this toxin induced apoptosis in susceptible HeLa cells (12). We therefore investigated whether Cry41Aa’s effects137
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on HepG2 cells were mediated by necrosis or apoptosis. Since necrotic and apoptotic processes can often be138
distinguished by intracellular ATP levels (13), we measured ATP levels following toxin exposure using the139
CellTitre-Glo assay. This showed that Cry41Aa induced a rapid reduction in ATP levels suggesting a necrotic140
pathway (Fig. 3A). To further test whether or not apoptosis was being induced by Cry41Aa in HepG2 cells, the141
levels of apoptotic mediators (Caspase 3/7) were assessed using the Caspase-Glo 3/7 Assay.  Fig. 3B shows that142
whilst the known apoptosis-inducing drug etoposide (14) resulted in an elevation of caspase levels, Cry41Aa had143
no such effect suggesting that it was not acting through an apoptotic pathway. Necrotic pathways within a cell are144
often associated with increases in reactive oxygen species (ROS) (15), including some induced by bacterial pore-145
forming toxins (16), and so we investigated whether or not Cry41Aa induced an increase in H2O2 in HepG2 cells146
using the ROS-Glo assay. The results (Fig. 4) show that there was no significant increase in ROS levels when147
compared to the positive control, menadione.148
149
To further investigate the mechanism of action of this toxin, its effect on the integrity of the HepG2 cell membrane150
was assessed using the CellTox Green cytotoxicity assay. Fig. 5A compares the effect of Cry41Aa with that of a151
positive control – a digitonin-based lysis solution (Promega G182B). A significant effect was seen with Cry41Aa152
after 90 minutes with the response after 300 minutes reaching the level seen with the positive control. After 300153
minutes the signal from cells treated with 100ȝg/ml etoposide or Cry1Ca remained at basal level (data not shown).154
A further assay (CytoTox-Glo) that also assesses membrane integrity supports the breakdown of the cell155
membrane (Fig 5B). The above data are consistent with the toxin causing cell death via the formation of pores156
resulting in cell swelling and eventually lysis. To investigate the size of the pores believed to be formed by the157
toxin various osmoprotectants were added to cells alongside the toxin and the CytoTox-Glo assay used to measure158
cell integrity. Fig. 6 shows that while the monosaccharides glucose and glucosamine failed to prevent the action159
of the toxin, the disaccharides and larger molecules of PEG did. This result is consistent with the toxin forming160
discrete pores rather than having a more general detergent-like action.  Microscopic analysis of treated and161
untreated cells showed that Cry41Aa caused swelling of the HepG2 cells within an hour of toxin addition (Fig 7).162
163
Creation of putative receptor-binding mutants164
The above data are all consistent with Cry41Aa acting as a pore-forming toxin - the same mechanism used by165
insecticidal Cry toxins that share the same protein fold. With the insecticidal Cry toxins, various exposed loops166
have been identified as being important in the interaction between the toxin and the target cell. Loop3 of domain167
II in particular is believed to have an important role in the initial binding to cell surface receptors (3). A candidate168
region (503 VRDNCPFAWPGYKQL 517) analogous to loop 3 was identified in Cry41Aa through sequence169
alignments with various insecticidal toxins whose structure has been solved experimentally (Cry1Aa, Cry3Aa,170
Cry3Bb, Cry4Aa, Cry4Ba, Cry5Ba). An homology model of the structure of Cry41Aa was created using Phyre2171
(17) (Fig. 8). The model is consistent with the above region being a loop at the apex of domain II. Since aromatic172
residues in this putative loop have previously been shown to be important for toxicity in other toxins (18) the three173
aromatic residues (F509, W511 and Y514) were individually converted to alanine to assess their role in HepG2174
cell killing. The three mutant toxins behaved exactly the same as the non-mutant form through expression,175
solubilisation, activation and purification suggesting that there had not been any significant effect on protein176
folding. All the toxins were tested for toxicity towards HepG2 cells using the CellTiter-Blue assay (Table 1). Of177
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the three mutants only Y514A retained toxicity, in contrast F509A and W511A had completely lost it. To further178
investigate the importance of the F509 amino acid additional substitutions were made in which the amino acid179
was replaced by a variety of both aromatic and non-aromatic ones. F509Y retained toxicity whereas F509W,180
F509S and F509L were inactive. For W511, substitutions to phenylalanine and tyrosine were created but only the181
former expressed well, this W511F mutant retained toxicity.  Thus of the substitutions made only F509Y and182
W511F retained activity supporting the hypothesis that aromatic amino acids in this region are important for183
toxicity.184
185
Discussion186
Of all the Bacillus thuringiensis Cry toxins with activity against human cell lines, the Cry41A class (parasporin187
3) most closely resembles their insecticidal counterparts. Sequence comparisons reveal that Cry41A contains the188
five highly conserved sequence blocks characteristic of the Cry toxins that are believed to possess the same three-189
domain structure (5). A key difference between these toxins is the presence of a ricin domain in Cry41A. This190
domain has been observed in many unrelated proteins and it has been proposed that it adds carbohydrate binding191
functionality (8). Several other toxins contain this domain including ricin (19), the HA33 component of the192
botulinum neurotoxin complex (20) and a large mosquitocidal toxin from Lysinibacillus sphaericus (21).193
Additionally, several other toxins from B. thuringiensis contain this domain: Cyt1Ca (22); Cyt1Da (23); Cry42Aa194
(24) and to a lesser extent the Cry35 family (25), although there is no evidence that the domain is involved in their195
toxicity. In contrast when this ricin domain was artificially fused to the C-terminus of the insecticidal Cry1Ac196
toxin the hybrid protein was found to be toxic to an increased range of insects (26). More recently this domain197
has been found in a 54kDa protein from B. thuringiensis subsp. israelensis (27). This latter protein is believed to198
have a function in stabilising a matrix surrounding the Cry toxins in this strain, potentially by interacting with199
carbohydrate residues. Unlike Cry41Aa, the ricin domain-containing, and apoptosis-inducing, toxin pierisin from200
the cabbage butterfly Pieris rapae is capable of killing HeLa cells (28). Mutagenesis studies suggested that the201
conserved QxW sequences in this domain were essential for toxicity, and were most likely involved in binding to202
glycosphingolipid receptors on the cell surface. In summary the ricin type beta-trefoil lectin like domain is widely203
found in B. thuringiensis, has carbohydrate binding functionality, and can help determine the specificity of a toxin.204
We tested the hypothesis that this additional domain could be responsible for the human cell toxicity205
associated with Cry41Aa by expressing recombinant clones with and without this domain and comparing their206
activities on a susceptible cell line. Expression of the two components of the Cry41Aa split toxin in a B.207
thuringiensis expression system resulted in two major bands. ORF2, which encodes the active portion of the toxin,208
has a predicted molecular weight of 93kDa but runs as a 78kDa protein in our gel system. Previously this toxin209
was reported as having a mobility on SDS PAGE corresponding to an 88kDa protein (7). ORF3 has a predicted210
molecular weight of 82kDa but in our system runs as a 107kDa protein. This is consistent with a previous report211
(7) in which ORF3 migrated at 120kDa. Cry toxins are generally believed to require proteolytic activation before212
they exert their toxic effect, and Yamashita et al. indeed found that solubilised Cry41Aa was not toxic to HepG2213
cells whereas toxin treated with proteinase K (giving a 64kDa fragment) was (7). Traditionally Cry toxins have214
been activated in vitro using trypsin. When we treated our recombinant Cry41Aa toxin with trypsin we did not215
get a 64kDa fragment but instead one that was only marginally smaller than the unprocessed toxin. We did216
however confirm that the trypsin-activated toxin showed activity against HepG2, whilst even a large excess of217
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unprocessed toxin had little activity. Upon treatment with trypsin (or proteinase K (7)) no ORF3 can be recovered218
suggesting that this protein does not possess a protease-resistant core. Even upon solubilisation, the ratio of ORF3219
to ORF2 drops suggesting that this protein is unstable. ORF3 resembles the C-terminal half of the larger Cry220
toxins, a region that is believed to be important for the expression and crystallization of the toxin within B.221
thuringiensis. This region is degraded when treated with proteases and plays no further part in the toxic mechanism222
(29). It seems likely then that ORF3 has a similar role to this C-terminal extension despite being expressed as a223
separate protein. When we attempted to express ORF2 in the absence of ORF3 a protein was detected at the correct224
size on SDS PAGE but the toxin could neither be solubilised nor activated with trypsin, suggesting that it had225
either not folded or not crystallized properly (data not shown).226
Deletion of the ricin domain resulted in expression of both ORF2 and ORF3 but with ORF2 migrating at227
66kDa as a result of the deletion of the 12kDa domain. Both ORFs solubilized in alkali and when treated with228
trypsin a stable band of ORF2, at the predicted size, was obtained. Deletion of the ricin domain does not therefore229
appear to have significantly altered the physical properties of this protein. When tested against HepG2 cells the230
deleted form had a similar toxicity to the unmodified toxin indicating that the ricin domain is not crucial for231
HepG2 toxicity. Our data are therefore consistent with a model in which both specificity and toxicity are232
determined by the core three-domain protein conserved between Cry41Aa and its insecticidal counterparts.233
Our data are also consistent with Cry41Aa killing HepG2 cells through a pore formation mechanism, i.e.234
in the same way that its insecticidal homologues are believed to kill their host cells. Rapid swelling was235
microscopically observed in susceptible cells, analogous to insect cells losing the ability to regulate osmotic236
pressure after exposure to Cry toxins (30).237
Experiments with osmoprotectants were used to determine the size of the primary lesions. Assays238
conducted at 3 hours (data not shown) and 6 hours post treatment produced results consistent with a pore diameter239
of <1 nm. This is smaller than previously estimated for some Cry toxins. For Cry1C the maximum radius was240
estimated at between 1 - 1.3 nm (31) and for Cry1Ac 1.2 – 1.3 nm (32). However previous experiments were241
performed in planar lipid bilayers in the absence of receptors or with membrane vesicles devoid of cellular content,242
and at a relatively high pH. Other experiments based on the Trypan blue exclusion method in C. fumiferana cells243
resulted in the detection of smaller pores. Channel radii induced by Bt kurstaki P1 toxin were less than 0.6 nm and244
for Bt aizawai and israelensis toxins between 0.6 - 1.0 nm (30). CyaA a hemolysin from B. pertussis, is also245
believed to form pores of 0.6 - 0.8 nm in diameter (33).246
Cry41Aa significantly affected cell viability within the first few hours, with an EC50 similar to a previous247
estimation (7). As with insecticidal Cry toxins, proteolytic activation of Cry41Aa was necessary for toxicity.248
Protoxin caused a small decrease in viability most likely due to activation by endogenous proteases since this was249
reduced when crystals were solubilised in the presence of protease inhibitors (data not shown). HepG2 exposure250
to Cry41Aa resulted in the cell membrane rapidly becoming permeable allowing the detection of two different251
cytotoxic markers. This effect was time and dose dependent and within 5 hours cytotoxic levels reached that252
caused by membrane permeabilizing agents. Toxin-induced ATP depletion, decrease in metabolic activity,253
swelling, and membrane damage followed a similar time course. Cry41Aa did not induce activation of caspases254
or oxidative stress even at low doses. All of the above data are consistent with a model in which Cry41Aa kills255
HepG2 cells through pore-formation followed by ROS independent necrosis. All these effects were cell and toxin256
specific. The structurally related three domain Cry1Ca toxin expressed and purified in the same way as Cry41Aa257
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did not affect HepG2 cells, and neither were HeLa cells affected by either Cry41Aa or Cry1Ca confirming the258
previously observed specificity (7).259
How these toxins could have evolved to target certain human cells remains a mystery and it is most likely260
that this activity does not represent their primary target. However understanding how these toxins target human261
cells is important when assessing the risk of the large scale use of new insecticidal toxins. Although we have262
shown that the specificity/toxicity of both types of toxin (insecticidal and human-active) may be mediated through263
the same region, ie loop3 of domain 2, there is currently not enough understanding of the nature of this interaction264
to be able to predict specificity on the basis of toxin sequence or structure. Furthermore previous work has shown265
that new specificities can be acquired through minor changes in the loop3 sequence (34). It is clear that266
considerably more work needs to be done, for example in fully understanding the nature of the interaction with267
the host cell, in order to understand how Bt toxins target particular hosts, even very dissimilar ones.268
269
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377
Toxin Toxicity
Cry41Aa Control (Yes)
F509A No
F509S No
F509L No
F509W No
F509Y Yes
W511A No
W511F Yes
Y514A Yes
378
Table 1. Activity of single amino acid substitution mutants towards HepG2 cells. Recombinant toxins were379
tested at a concentration of 12µg/ml and assayed using CellTiter-Blue. They were considered toxic if their380
activity was not significantly different to the non-modified toxin. They were considered non-toxic if their381
activity was not significantly different to the buffer control.382
383
384
385
Figure Legends386
387
Figure 1. Solubilization and activation of the Cry41Aa toxins. Lanes 1, 3 and 5 contain the unmodified protoxin388
and lanes 2, 4 and 6 contain the ricin domain deleted derivative. Lanes 1 and 2: unprocessed protoxin; lanes 3 and389
4: alkali solubilized protoxins; lanes 5 and 6: trypsin-activated toxins. M: molecular weight markers (in kDa).390
391
Figure 2. Toxicity of recombinant Cry41Aa. A) HepG2 cells were seeded at a density of 5000 cells per well392
and treated with either solubilised or trypsin-activated Cry41Aa, or trypsin-activated Cry41Aaǻricin for 20 hours393
and cell viability assessed using the CellTiter-Blue assay. B) Trypsin-activiated Cry41Aa and Cry1Ca were used394
to treat either HepG2 or HeLa cells for 20 hours and cell viability assessed using the CellTiter-Blue assay.395
Etoposide (100µg/ml) and Triton X-100 (0.1%) were used as positive controls and buffer alone as a negative396
control. C) Cells were treated with the different toxin concentrations shown for 20 hours prior to CellTiter-Blue397
assay. In each assay percentage viability was calculated relative to a buffer only mock control and the error bars398
represent one standard error of the mean.399
400
Figure 3. Assessment of ATP and Caspase 3/7 levels in HepG2 cells after exposure to Cry41Aa. A) HepG2401
cells were dosed with Cry41Aa (12 µg/ml) or buffer. Luminescence was measured at different time points using402
the CellTiter-Glo assay B) Caspase levels were measured using the Caspoase-Glo 3/7 assay following exposure403
to the stated concentrations of toxin.404
405
Figure 4. Estimation of hydrogen peroxide levels in HepG2 cells following treatment with Cry41Aa. HepG2406
cells were dosed with H2O2 substrate and incubated with Cry41Aa (10 µg/ml), Menadione (50 µM), Cry1Ca (10407
µg/ml), digitonin (13.1 µg/ml) or buffer only for the indicated amount of time.408
409
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Figure 5. Assessment of the effect of Cry41Aa on the integrity of HepG2 cell membranes. A) HepG2 cells410
were treated with either 12µg/ml Cry41Aa, buffer only or a digitonin-based lysis solution for the times indicated411
and membrane integrity measured using the CellTox Green assay B) HepG2 cells were treated with either 5µg/ml412
Cry41Aa, 5 and 58 µg/ml Cry41Aa protoxin, 5 and 80 µg/ml Cry1Ca, buffer only or the detergent Triton X100413
solution for the times indicated and membrane integrity measured using the CytoTox-Glo assay. Damage is414
indicated relative to cells treated with 43.7 µg/ml digitonin.415
416
Figure 6. The effect of different osmoprotectants on HepG2 membrane permeability 6 hours after exposure417
to Cry41Aa. Cells were treated with various osmoprotectants (30 mM) or mock (dH2O) for 10 minutes. This was418
followed by the addition of either Cry41Aa (55 µg/ml) or buffer. Luminescent readings were taken 6 hours later419
using CytoTox-Glo cell assay. All data were plotted as the percentage of digitonin (11.4 µg/ml) treated cells.420
421
Figure 7. Effect of Cry41Aa on HepG2 morphology. HepG2 cells (1.5 x 104 per chamber) were treated with422
5.5µg/ml Cry41Aa for the times indicated and then viewed by DIC microscopy. The scale bar represents 20ȝm.423
424
Figure 8. Homology model of Cry41Aa. The model was created using Phyre2 and displayed using Chimera1.8.425
Amino acids F509 and W511 are highlighted.426








